Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACLAIMS: Paliperidone vs Haloperidol in Schizophrenia
NCT01136772Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2011
- Primary completion
- Jul 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia, schizoaffective disorder, sponsored by New York State Psychiatric Institute. Started Mar 2011; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01136772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136772.